Agoracom Blog

Candente Copper $DNT.ca Engages Yaku for Environmental Assessment and Protection at Canariaco Copper Deposit $FCX.ca $TECK.ca $FSUGY $PER.ca

Posted by AGORACOM at 8:29 AM on Thursday, March 18th, 2021
http://blog.agoracom.com/wp-content/uploads/2020/08/candente-copper-for-blog1.jpg
  • Engaged to conduct and continue previous baseline studies at the Cañariaco Project
  • 9B lbs copper, 2M oz gold and 54M oz silver in: Measured and Indicated Resources

Candente Copper Corp. (TSX: DNT, BVL: DNT) (“Candente Copper”, “the Company”) is pleased to announce that Yaku Consultores (“Yaku”) has been engaged to conduct and continue previous baseline studies at the Cañariaco Project located in Northern Peru. The work will be part of environmental impact studies and habitat protection for all exploration phases of permitting including drilling and also for the community and regional stakeholders.  

“We are excited to be moving the Cañariaco project forward with Yaku’s environmental work and new engineering studies underway by Ausenco. Timing couldn’t be better as Cañariaco has been identified by both Goldman Sachs and Deutche Bank as one of the top copper projects needed to supply the upcoming supply-demand shortage for copper,” says Joanne Freeze, President and CEO, Candente Copper.

Yaku is comprised of a team of highly experienced professionals focused on providing quality environmental and social consulting services. These services contribute to the sustainable development of the environment and exceed regulations.

Candente Copper has recently obtained the respective authorizations from SERFOR and PRODUCE (Peruvian authorities for National Forest and Wildlife Services and the Ministry of Production) to conduct new monitoring of Water Quality, Air Quality, Noise Levels and Biology, Wild Flora and Fauna and Hydrobiology. Yaku has begun collecting new data within the project area which will add significantly to the studies that Candente Copper has been conducting such since 2004.

Given the difficult situation for the community with the COVID-19 epidemic, the company is also collaborating with local health facilities to assist in the protection and care of citizens in the area surrounding Cañariaco. To date, the Company has assisted with PPE supplies and the operation of emergency health equipment.

About Candente Copper

Candente Copper is a mineral exploration company engaged in the acquisition, exploration, and development of mineral properties. The Company is currently focused on its 100% owned Cañariaco project, which includes the Feasibility stage Cañariaco Norte deposit as well as the Cañariaco Sur deposit and Quebrada Verde prospect, located within the western Cordillera of the Peruvian Andes in the Department of Lambayeque in Northern Peru.  

Please see https://www.candentecopper.com/investors/presentations for details from previous resource and engineering studies which delineated 9B lbs copper, 2M oz gold and 54M oz silver in: Measured and Indicated Resources of 752.4 million tonnes grading 0.45% copper, 0.07 grams per tonne (“g/t”) gold and 1.9 g/t silver (0.52% Cu equivalent) containing 7.533 B lb Cu, 1.67 M oz Au and 45.24 M oz Ag and Inferred Resources of 157.7 million tonnes grading 0.44% copper, 0.06 g/t gold and 1.8 g/t silver containing 1.434 B lb Cu, 0.3M oz Au and 8.932 M oz Ag.

Tags: , , , , , , ,
Posted in All Recent Posts, Candente Copper | Comments Off on Candente Copper $DNT.ca Engages Yaku for Environmental Assessment and Protection at Canariaco Copper Deposit $FCX.ca $TECK.ca $FSUGY $PER.ca

@Novamind_Inc $NM.ca $NVMDF Partners with Merck $MRK for New Treatment-Resistant Depression Trial $RVV.ca $MMED $PSYC.ca $FTRP.ca $CMPS $NUMI.ca

Posted by AGORACOM-JC at 8:15 AM on Thursday, March 18th, 2021

Novamind’s subsidiary, Cedar Clinical Research, to serve as a key clinical research site

TORONTO, ON / March 18, 2021 / Novamind Inc., (CSE:NM)(OTC PINK:NVMDF)(FSE:HN2) (“Novamind” or the “Company”), a leading mental health company specialized in psychedelic medicine, is pleased to announce that its wholly-owned subsidiary, Cedar Clinical Research (“CCR”) has been selected as a key research site for a clinical trial focused on treatment-resistant depression by Merck & Co., (“Merck”), a world-leading pharmaceutical company.

The phase II study will assess the efficacy and safety of a new Merck drug for treatment-resistant depression (TRD), a mental health condition that affects approximately 30% of people who suffer from major depressive disorder1. The study is titled “A Phase 2a, Randomized, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of MK-1942 Added to Stable Antidepressant Therapy in Participants With Treatment-Resistant Depression.” The clinical trial begins enrolling individuals in March 2021.

“We’re proud to partner with Merck and support its innovative neuroscience work to develop a potential new drug for treatment-resistant depression,” said Dr. Reid Robison, Chief Medical Officer of Novamind and Principal Investigator at CCR. “CCR has unique expertise conducting clinical trials and research studies in neuropsychiatry, for a variety of sponsors. This exciting research opportunity with Merck exemplifies a growing pipeline of opportunities for us to provide contract research services to leading drug developers.”

The selection of Novamind’s Cedar Clinical Research for this significant study reflects its deep experience hosting phase I to phase IV clinical trials, many of them focused on psychedelic medicines, and emerging therapies in neuropsychiatry. CCR’s clinical trial expertise includes trial design, patient recruitment, and patient management for drug development sponsors including pharmaceutical companies, academic institutions and non-profit groups.

Yaron Conforti, CEO and Director of Novamind said: “Under Dr. Robison’s leadership, Cedar Clinical Research has proven itself as a best-in-class research site for emerging mental health therapeutics. We’re excited to work with Merck, a world-class pharmaceutical company, to advance research for innovative mental health treatments.”

Cedar Clinical Research is currently contracted for seven clinical trials with various sponsors, in addition to its ongoing contributions to numerous clinical trials for psychedelic medicine, including most notably the MAPS-sponsored phase II clinical trial of MDMA-assisted psychotherapy for eating disorders, a ketamine-assisted psychotherapy study (KAP) for end-of-life palliative care with the Ketamine Research Foundation, and a ketamine study to treat suicidal ideation in partnership with the University of Texas, Austin. CCR became widely known for its work in psychedelic medicine following Dr. Robison’s role as a Principal Investigator in Utah for a clinical trial that led to the first approval of Janssen’s Spravato™ in March 2019.

To learn more about the Merck study with Cedar Clinical Research, please visit this link.

About Novamind

Novamind is a leading mental health company enabling safe access to psychedelic medicine through a network of clinics, retreats, and clinical research sites. Novamind provides ketamine-assisted psychotherapy and other novel treatments through its network of Cedar Psychiatry clinics and operates Cedar Clinical Research, a contract research organization specialized in clinical trials and evidence-based research for psychedelic medicine. Both Cedar Psychiatry and Cedar Clinical Research are wholly-owned subsidiaries of Novamind. For more information on how Novamind is enhancing mental wellness and guiding people through their entire healing journey, visit www.novamind.ca.

Contact Information

Novamind

Yaron Conforti, CEO and Director
Telephone: +1 (647) 953 9512
Bill Mitoulas, Investor Relations
Email: [email protected]

Forward-Looking Statements

This news release contains forward-looking statements. All statements other than statements of historical fact included in this release are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from the Company’s expectations including the risks detailed from time to time in the Company’s public disclosure. The reader is cautioned not to place undue reliance on any forward-looking information. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and the Company will update or revise publicly any of the included forward-looking statements as expressly required by applicable laws.

1 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6982454/#!po=0.537634

SOURCE: Novamind Inc.

Tags: , , ,
Posted in Novamind Inc. | Comments Off on @Novamind_Inc $NM.ca $NVMDF Partners with Merck $MRK for New Treatment-Resistant Depression Trial $RVV.ca $MMED $PSYC.ca $FTRP.ca $CMPS $NUMI.ca

VIDEO – POET Technologies $PTK.ca $POETF Discusses Significant Progress on Super Photonics Xiamen Joint Venture

Posted by AGORACOM-JC at 6:54 PM on Wednesday, March 17th, 2021

When a small cap company enters into a developer and supply agreement with a technology leader in its space AND can’t name the company, that is typically a very good thing.

Understanding the world of Photonics isn’t the easiest thing small cap investors have had to understand.  In fact, it may be the very hardest thing they’ve ever had to understand.  However, given the fact we are the very reason current photonics devices aren’t living up to snuff trying to keep up with our surfing, streaming, binging and zooming – you start to see why understanding photonics and POET Technologies could open up investors to a whole new world.

We went beyond the press release with POET management to discuss its significant progress on Super Photonics Xiamen Joint Venture.

Joint Venture Highlights

  • Valued at $USD 50M
  • Revenue opportunity of $USD 250M annually by 2024-2025
  • Ability to scale production rapidly without cash investment by POET.       

Sit back, relax and watch this powerful interview with Poet Technologies.

Tags: , , , , ,
Posted in AGORACOM Via Satellite, POET Technologies | Comments Off on VIDEO – POET Technologies $PTK.ca $POETF Discusses Significant Progress on Super Photonics Xiamen Joint Venture

VIDEO – KWESST $KWE.ca $KWEMF Hits A Key Milestone In The Digitization of The Modern Army $WRTC $BYRN.ca $PAT.ca $POWW

Posted by AGORACOM-JC at 4:10 PM on Wednesday, March 17th, 2021

If you haven’t heard of KWESST Micro Systems (KWE:TSXV) you’re not alone because the Company just listed for trading a couple of months ago – and it is probably the coolest new listing of 2020 if you love high-tech, covert defense systems that we only get to see in Tom Cruise movies.

KWESST is a leader in “soldier systems” which are technologies that increase the capabilities of soldiers,  Let’s be clear right off the start, KWESST doesn’t sell weaponry.  Rather, it sells technologies that make a big difference to the safety and effectiveness of soldiers.

For example, out in a field of combat, soldiers emit Electro Magnetic (EM) signatures that make them detectable by enemy combatants.  KWESST has a battlefield decoy system that creates multiple false phantom signatures to spoof adversaries.  This picture is worth 1,000 words.

soldier

Or perhaps the “TASCS” – Tactical Awareness and Situational Control System

An App and snap-on weapon adaptor that enables real-time streaming of situational awareness data of any kind from any source, including drones, direct to smart display devices and operational assets, for a common operating picture and networked engagement.

Devices-10

The company successfully achieved an important milestone under the contract announced in December 2020 for a key military customer.

This milestone entailed the integration of the Company’s TASCS IFM (Integrated Fires Module) for the 81mm Mortar Fire Control System into the Android Tactical Assault Kit (ATAK), the preeminent battlefield management system for NATO countries . As a result, the Company will now proceed to the next phase of the contract, involving live-fire trials at various U.S. military bases.

A world-first in digitizing the function of a mortar team, from the identification of the target to the aiming of the mortar.

We could go on about many other such technologies created by KWESST but this is AGORACOM after all and we want to get down to the business of KWESST, the highlights of which are as follows: 

  • A developer of next-generation systems for forces around the world, including those of NATO and its allies
  • A leadership team whose experience spans decades and hundreds of millions of dollars in military and homeland security contracts
  • A sales and distribution network of agents that spans the globe
  • Partnerships with globally recognized OEM’s, including Samsung
  • Received a follow-on order for $1.1 Million from a key US Military Customer. 

And last but not least, a secret weapon in its Executive Chairman David Luxton, whose companies under his leadership have generated over $1,000,000,000 (Yes, BILLION).

The soldier systems market is projected to hit $14.5 Billion by 2023 and, up until  now, small cap investors have never had a company to participate in this lucrative (and SUPER COOL) market.

Tags: , , , , ,
Posted in AGORACOM Via Satellite, All Recent Posts, Featured, KWESST Micro Systems Inc. | Comments Off on VIDEO – KWESST $KWE.ca $KWEMF Hits A Key Milestone In The Digitization of The Modern Army $WRTC $BYRN.ca $PAT.ca $POWW

CLIENT FEATURE: $HOLL $HSTRF Powering Class-leading #Cannabis Products From Seed to Shelf $CRON $GTBIF $INDS $META.ca $FAF.ca $WEED.ca

Posted by AGORACOM at 2:46 PM on Wednesday, March 17th, 2021

CLIENT FEATURE: Hollister Biosciences Inc. (HOLL: CSE) – Acquiring, developing and powering class-leading cannabis consumer products.

WHY HOLLISTER?

  • Vertically integrated, high-margin cannabis company with high-quality cannabis and hemp products in over 280 dispensaries throughout California and over 90 dispensaries throughout Arizona, plus joint ventures, licensing agreements, and partnerships with global brands.
  • Hollister controls the whole process from manufacturing to sales, to distribution. From seed to shelf. 
  • Fully licensed and compliant and have established a statewide distribution within California for medical and recreational cannabis.
  • The U.S. market for cannabis-infused drinks is expected to grow to $1.4 billion by 2024. Zenith Global.
  • The market for hemp-derived CBD products was USD $591 Million in 2018, expected to reach USD $22 Billion by 2022.

Recent Highlights:

Q4 2020 Financial Highlights:

Q4 2020 Performance Includes CDN $14.93 Million in Revenue With an Estimated CDN $2.53 Million in EBITDA a YoY Revenue Increase of 3215% from Q4 2019

March:

February:

January

December:

Market Analysis/Overview:

What is Hollister?

  1. Hollister Biosciences Inc. is a multi-state company with a portfolio of innovative, high-quality cannabis & hemp branded consumer products and white-labelling manufacturing. Products are sold in 370 dispensaries across Arizona and California.
  2. Hollister Biosciences owns 100% of Venom Extracts, a category-leading brand that sold over 4 million grams in 2020, accounting for up to 30 percent of category sales in Arizona.
  3. Products from Hollister Biosciences Inc. include HashBone, the brand’s premier artisanal hash-infused pre-roll, along with concentrates (shatter, budder, crumble), distillates, solvent-free bubble hash, pre-packaged flower, pre-rolls, tinctures, vape products, and full-spectrum high CBD pet tinctures. 
  4. The wholly-owned California subsidiary Hollister Cannabis Co is the 1st state and locally licensed cannabis company in the city of Hollister, CA birthplace of the “American Biker”.

What Brands Does Hollister Own?

Hollister $HOLL.ca $HSTRF 

$CRON $GTBIF $INDS $META.ca $FAF.ca $WEED.ca

Hollister Biosciences Inc. is traded on the CSE as HOLL.

For more information, visit: https://hollisterbiosciences.co/investors/

FULL DISCLOSURE: Hollister Biosciences Inc. is an advertising client of AGORA Internet Relations Corp.

Tags: , , , , , , ,
Posted in Hollister Biosciences | Comments Off on CLIENT FEATURE: $HOLL $HSTRF Powering Class-leading #Cannabis Products From Seed to Shelf $CRON $GTBIF $INDS $META.ca $FAF.ca $WEED.ca

Maitri Health Technologies $MTEC.ca Announces Health Canada Approval of Domestically Manufactured N95 Masks $DOC.ca $DOCRF $WELL.ca $PRN.ca

Posted by AGORACOM at 10:13 AM on Wednesday, March 17th, 2021
Maitri Health Technologies MTEC
  • Medical-grade protective gear designed and made in Canada ;
  • Offers greater certainty regarding source, quality and timely delivery of genuine N95 masks.

VANCOUVER, BC , March 17, 2021 /CNW/ – Maitri Health Technologies Corp. (“Maitri”) (CSE: MTEC) (FRA: D84), a global platform for healthcare supply security, today announced the availability of N95 medical-grade protective masks, one of the few, domestically manufactured N95 masks to receive Health Canada certification.

Health Canada Approved N95 Mask Offered By Maitri Health Technologies. (CNW Group/Maitri Health Technologies Corp.)

N95 masks are among the most in-demand and difficult to source pieces of personal protective equipment (PPE) commonly used by hospital, healthcare and other frontline workers. N95 masks filter out at least 95 per cent of very small particles, including airborne droplets.

Maitri’s N95 masks, manufactured in Port Coquitlam, B.C. through an exclusive partnership with INNO Lifecare, were approved by Health Canada in March.

“Maitri is delivering what governments and organizations across Canada have sorely needed and requested since the beginning of the pandemic – a domestically manufactured and certified N95 mask,” said Andrew Morton, CEO of Maitri.

Read More: https://agoracom.com/ir/MaitriHealthTechnologies/forums/discussion/topics/757491-maitri-health-technologies-announces-health-canada-approval-of-domestically-manufactured-n95-masks/messages/2308523#message

Tags: , , , , , ,
Posted in Maitri Health Technologies Corp. | Comments Off on Maitri Health Technologies $MTEC.ca Announces Health Canada Approval of Domestically Manufactured N95 Masks $DOC.ca $DOCRF $WELL.ca $PRN.ca

$FANS.ca $FUNFF Announces Strategic Technology Partnership With $TGS.ca For Major Live Esports Events $DKNG $PENN $GAN $ESPO $AESE $EGLX.ca $BRAG.ca $FDM.ca $SCR.ca $BRAG.ca $TNA.ca $FDM.ca $JJ.ca

Posted by AGORACOM at 9:46 AM on Wednesday, March 17th, 2021

  • The partnership will launch prediction games for major live esports events
  • “The partnership with TGS Esports brings forth a new platform that will enable us to capture new opportunities within the fast-growing esports market,” said Scott Burton, CEO of FansUnite.

VANCOUVER, BC, March 17, 2021 /CNW/ – TGS Esports Inc. (“TGS” or the “Company”) (TSXV: TGS) (FRA: 5RH)) is pleased to announce that it has entered into a strategic partnership with FansUnite Entertainment Inc. (CSE: FANS) (OTCQB: FUNFF) (“FansUnite”), to launch live esports tournaments prediction games.

TGS livestream demo showcasing FansUnite’s stream prediction platform

TGS All New Prediction Game (CNW Group/TGS Esports Inc)

TGS partners with organizations and brands to build and grow their esports communities via tournaments, broadcast production and events. Through the partnership, FansUnite will incorporate its technology solutions into TGS events to establish a new prediction platform where live audience predictions can be placed on multiple outcomes within every white-label esports event run by TGS. Viewers can make live predictions during TGS events for which they can win prizes if their selections are correct. 

Esports revenue in 2020 was over $1 billion[1], excluding revenues from betting. TGS has built white-label esports experiences for over 15 brands, interacting with over 200,000 gamers and by offering prediction games, TGS is able to increase the level of engagement between fans and brands.

Additionally, the prediction games from the platform will be featured on TGS’ Pepper Esports platform which will enable all tournament organizers to offer predictions and rivalry challenges in their tournaments to their viewers.

“Live predictions is a feature our brand partners have been asking us to implement for a long time.” said Spiro Khouri, CEO of TGS Esports Inc. “By implementing FansUnite’s technology into our esports events TGS is able to increase the level of engagement between fans and brands.”

“The partnership with TGS Esports brings forth a new platform that will enable us to capture new opportunities within the fast-growing esports market,” said Scott Burton, CEO of FansUnite. “TGS collaborates with numerous esports event organizers who have a large following of enthusiastic esports gamers who like to participate in their events. Our online betting solutions coupled with TGS esports platform will enable us to attract a new and widening audience from these events.”

For more information, click here.

Tags: , , , , , , , , , , , , , ,
Posted in FansUnite Entertainment Inc., TGS ESports Inc. | Comments Off on $FANS.ca $FUNFF Announces Strategic Technology Partnership With $TGS.ca For Major Live Esports Events $DKNG $PENN $GAN $ESPO $AESE $EGLX.ca $BRAG.ca $FDM.ca $SCR.ca $BRAG.ca $TNA.ca $FDM.ca $JJ.ca

VIDEO – Watch Our Latest Shareholder Q&A With PyroGenesis

Posted by AGORACOM-JC at 6:25 PM on Tuesday, March 16th, 2021

Tags: , , , , , ,
Posted in AGORACOM Via Satellite, PyroGenesis Canada Inc. | Comments Off on VIDEO – Watch Our Latest Shareholder Q&A With PyroGenesis

CLIENT FEATURE: Binovi VISN.ca $BNVIF Sets Sights on Disrupting $600bn Sports Performance Market $EYPT $KALA $PTON $WELL.ca $DOC.ca $DOCRF

Posted by AGORACOM at 5:51 PM on Tuesday, March 16th, 2021
This image has an empty alt attribute; its file name is 300-x-300.jpg

CLIENT FEATURE: Binovi Technologies (VISN: TSX-V) Sets Sights on Disrupting $600bn Sports Performance Market

Why VISN?

  • Binovi is well-positioned to further commercialize and capitalize on the massive demand for Vision Therapy and Training For Athletes and Education.
  • Strong IP Portfolio
  • 1 in 4 people on the planet have vision problems that go beyond simply not being able to read those letters on the wall and requiring a prescription.
  • Since the launch of Binovi, more than 800 organizations have been registered and have used the platform for vision therapy, sports vision performance.
  • Clients Include:
    • Dallas Stars (NHL)
    • Chicago Cubs (MLB)
    • Sporting KC (MLS)
    • Tennis Canada
    • Showcased During NFL Scouting Combine
  • Company’s Vision Therapy Products Used In:
    • Over 1,500 Practices
    • 20 Countries 
  • These organizations have created nearly 31,000 users and have completeded more than 400,000 active sessions centred around the Binovi Library list of activities, custom activities created by member organizations.
  • Flagship “Binovi” Is State-Of-The-Art Platform
    • Measures 14 Key Vision Skills
    • Essential For Maximizing Brain Performance
  • Signed Sports Vision Partnership With Eli Wilson Goaltending
    • World Leader In Goaltending Development
    • 600 Active Goaltending Camp Participants
    • 50,000 Global Aspiring Goaltenders
  • Announced a strategic partnership with STEM Sports
  • Expanded its global reseller network with a partnership with Sport-Orthèse, major European sports e-seller

Binovi Technologies – Vision Performance and Vision Therapy

Recent Highlights

Q3 2020 Financial Highlights:

  • Revenue increased by more than 100% in Q3 2020, in comparison to Q3 2019
  • A combined $3.12 Million raised through private placement subscriptions with strategic investors.

February:

  • Binovi Partners with European Reseller Sport-Orthese to Commercialize Binovi Hardware
    • This move demonstrates Binovi’s ongoing efforts to optimize its revenue opportunities within its global strategy.

January

  • Binovi Partners with STEM Sports(R) to Contribute to K-8 Curriculum that will be Binovi Connect Enabled
  • Binovi Technologies Q3 2020 Revenue Up, Increasing Top-Line and Gross Margin Results

Market Analysis

  • Sports Performance Market is a $600 Billion Opportunity
  • Vision Therapy captures 3% of a $36B Yearly Vision Market today.
  • Vision Therapy grew by 22% in 2020 and won 4% of the $39B Yearly Market in 2020 with organic growth.
  • VISN’s sights are set on disrupting the sports performance industry in 2021, as we receive engagement from leaders within the human performance – sports performance industry.
  • The size of the sports performance market reached a value of nearly $488.5B in 2018, having grown at a compound annual growth rate (CAGR) of 4.3% since 2014, and is expected to grow at a CAGR of 5.9% to nearly $614.1B by 2021.
VSN-Pic-2

What is VISN?

  1. Binovi is a best-in-class neuro-visual performance platform designed to test, analyze, track, and report on individual cognitive performance.
  2. Binovi is designed for vision optimization and the enhancement of cognitive skills related to human performance.
  3. Binovi Technologies Corp (TSX-V: VISN | OTCQB: BNVIF) is reshaping V Education, Vision Care, and Performance through Purposeful, Powerful Vision Training
  4. Utilizing in-office and home-based activity protocols, the innovative Binovi platform helps optometric practices gain greater results, faster, with improved patient satisfaction in areas ranging from sports performance to binocular vision abnormalities.
  5. In a world in which competitors are seeking an edge, Binovi vision training develops faster brains to deliver that edge.
VSN-Pic-1

How Does VISN Work?

  1. Binovi combines hardware, software, specialized expert knowledge, and unique data insights to deliver customized, one-on-one training and learning protocols ideal for K-12 Students, Vision Care Specialists, and Sports Performance testing and training.
  2. Binovi goes far beyond fixing eyes that simply can’t see a bunch of letters on an eye chart.  Rather, Binovi delivers higher-performing brains by optimizing the performance of the eyes. Binovi synchronizes your eyes and your brain to deliver maximum performance for athletes and students.
  3. Designed for vision optimization and the enhancement of skills related to cognitive performance, Binovi provides measurable results in less time, and with less effort.
VSN-Pic-3

Who Uses VISN?

Binovi is currently used in over 20 countries and supported by recognized optometry leaders.

  1. Patients: Optometrist-lead vision therapy for patients suffering from developmental issues or recovering from injury.
  2. Optometry Professionals: Practicing optometrists and vision therapists working in development, rehabilitation, and healthy ageing.
  3. Athletes: Optometry-backed tools to help improve sports vision performance indicators like reaction time and hand-eye coordination.
VISN-Pic-4

Binovi $VISN.ca $BNVIF

$EYPT $KALA $PTON $WELL.ca $DOC.ca $DOCRF

Binovi Techologies Corp. is traded on the TSX.V as VISN.

For more information, visit: https://binovi.com/investors/

FULL DISCLOSURE: Binovi Technologies is an advertising client of AGORA Internet Relations Corp.

Tags: , , , , ,
Posted in Binovi Technologies Corp. | Comments Off on CLIENT FEATURE: Binovi VISN.ca $BNVIF Sets Sights on Disrupting $600bn Sports Performance Market $EYPT $KALA $PTON $WELL.ca $DOC.ca $DOCRF

$TGS.ca Announces Record Viewership in Back to Back Weekend Tournaments $DKNG $PENN $GAN $ESPO $AESE $EGLX.ca $BRAG.ca $FDM.ca

Posted by AGORACOM at 11:02 AM on Tuesday, March 16th, 2021

*Tournaments break participation and viewership records for the company
*Top channel in Twitch’s popular RocketLegue category

VANCOUVER, BC, March 16, 2021 /CNW/ – TGS Esports Inc. (“TGS” or the “Company”) (TSXV: TGS) (FRA: 5RH) is pleased to announce two record-shattering weekends of white label events.

Over the weekend of March 5-7th, TGS ran four events for its partner brands, including Telcel and NorQuest College. These events had 1400+ players participating and attracted 35,000+ viewers on their TGS produced live streams, setting new participation and viewership records for the company.

The following weekend, March 12-14th, TGS ran two more events for its partner brands that attracted 96,000+ viewers, which was another new and significant participation and viewership record for TGS. Both of these streams featured the popular game title Rocket League, and both streams led Twitch’s Rocket League viewership category throughout the day.

“Brands spent over $500 million on esports events & sponsorship in 20201 and they are looking to spend their money where it has the greatest impact,” said Spiro Khouri, CEO of TGS. “We make it an easy decision for brands to spend their money with TGS.”

The weekend’s event streams can be viewed at:

To read more about TGS, click here.

Tags: , , , , , , , , , ,
Posted in TGS ESports Inc. | Comments Off on $TGS.ca Announces Record Viewership in Back to Back Weekend Tournaments $DKNG $PENN $GAN $ESPO $AESE $EGLX.ca $BRAG.ca $FDM.ca

« Older Entries
Newer Entries »